lifestyle.brownplanet.com

Author: BERRY & COMPANY PUBLIC RELATIONS

GRIN Therapeutics’ Pivotal Phase 3 Beeline Study Initiated in Europe

May 4, 2026
ITF Therapeutics LLC Presents New Data and Analyses on Givinostat for Treatment of Duchenne Muscular Dystrophy at 2026 MDA Clinical and Scientific Conference

March 13, 2026
ITF Therapeutics LLC Announces Multiple Data Presentations at 2026 MDA Clinical and Scientific Conference

March 11, 2026
GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder

January 9, 2026
GRIN Therapeutics to Present on Global Phase 3 Beeline Clinical Trial of Radiprodil at American Epilepsy Society Annual Meeting

December 4, 2025
Solu Therapeutics Announces Presentation of Trial in Progress on STX-0712 for Treatment of Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting

December 2, 2025
Neurvati Neurosciences Appoints Carlos Martin as Chief Commercial Officer

November 16, 2025